CDZ173,
leniolisib,
Leniolisib,
1354690-24-6,
UNII-L22772Z9CP,
L22772Z9CP,
(S)-1-(3-((6-(6-methoxy-5-(trifluoromethyl)pyridin-3-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)propan-1-one,
Leniolisib [INN],
Leniolisib (CDZ173),
Leniolisib (USAN/INN),
CDZ173-NX,
SCHEMBL323054,
CDZ173,
GTPL9424,
CHEMBL3643413,
CDZ-173,
MWKYMZXCGYXLPL-ZDUSSCGKSA-N,
BDBM118299,
MFCD30470232,
CS-7524,
SB18839,
Example 67 [WO2012004299],
1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-ylamino]-pyrrolidin-1-yl}-propan-1-one,
HY-17635,
A16796,
D11158,
US8653092, 67,
1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one,
1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-y,
1-Propanone, 1-((3S)-3-((5,6,7,8-tetrahydro-6-(6-methoxy-5-(trifluoromethyl)-3-pyridinyl)pyrido(4,3-d)pyrimidin-4-yl)amino)-1-pyrrolidinyl)-,
9NQ,
leniolisib(CDZ 173),